ctDNA and Tumor Biomarkers Predict Giredestrant Response
In a groundbreaking advancement for precision oncology, researchers have unveiled a novel set of biomarkers capable of predicting patient response...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In a groundbreaking advancement for precision oncology, researchers have unveiled a novel set of biomarkers capable of predicting patient response...
In the evolving landscape of oncology, a pivotal international phase III clinical trial—NRG-LU005—has recently reshaped the understanding of treatment paradigms...
A groundbreaking study spearheaded by researchers at UCLA has illuminated a promising approach to assist women who have survived cervical...
A groundbreaking study published in the March 2026 issue of the Journal of the National Comprehensive Cancer Network (JNCCN) reveals...
In an ambitious endeavor to decode the intricate spatial dynamics within ZFTA-RELA supratentorial ependymomas, researchers have illuminated how malignant and...
In a groundbreaking advancement that could redefine the paradigm of targeted cancer therapy, researchers have unveiled the first-in-human study results...
Cancer remains one of the most formidable challenges in modern medicine, rooted deeply in the genetic anomalies within cells. However,...
In a groundbreaking study poised to reshape our understanding of bone biology, researchers have unveiled a novel molecular pathway by...
In recent years, the study of circulating tumour DNA (ctDNA) has ignited a transformative wave in oncology, offering a dynamic...
A groundbreaking study published in Nature reveals how ageing triggers a metabolic shift in cancer cells, unveiling a promising therapeutic...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine